Efficacy of a Partially Hydrolyzed Formula, Containing Lactobacillus Reuteri, for Infant Colic
Infant Colics
About this trial
This is an interventional treatment trial for Infant Colics focused on measuring infants, colic
Eligibility Criteria
Inclusion Criteria:
Full-term infants (≥37 weeks gestation at birth); Exclusively formula fed infants at time of enrolment; Infants suffering from IC according to Rome III criteria (Appendix 1); Age < 4 months of life; 5-minute Apgar score ≥7; Birth weight ≥2500 g.
Exclusion Criteria:
Consumption of formula containing probiotics, pHF or with reduced lactose content at time of enrolment; Major medical problem or acute illness, including gastroesophageal reflux, cow's milk protein allergy History of antibiotic treatment before or during the study; History of probiotic or L reuteri supplementation; History of any allergies to any of the ingredients in the probiotic L reuteri Concurrent participation in another clinical trial. Birth weight < 2500 g; Failed to thrive; Breastfed infants; NAN (to avoid the formula switch effect).
Sites / Locations
- Annamaria StaianoRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
group 1
group 2
Patients with infantile colics who will receive the milk formula NAN Sensitive, Nestlè
Patients with infantile colics who will receive the milk formula NAN Optipro, Nestlè